PLENARY LECTURE

Omar Abudayyeh, PhD

Assistant Professor at Harvard Medical School / Brigham and Women's Hospital / MGB Gene and Cell Therapy Institute

Programmable Technologies for Engineering Biology

PLENARY LECTURE

Palani Palaniappan, PhD

Chief Technical Operations & Quality Officer @ Flagship Pioneering

CMC for GCT - talk title TBA 

 PLENARY LECTURE

Panteli Theocharous, FIBMS, M.S., PhD, FRCPath

CEO @ VectorGen

Talk title - TBA

 Prof. Mimoun Azzouz, PhD

School of Medicine & Population Health, Chair of Translational Neuroscience, Director of GTIMC @ University of Sheffield, UK

ARDAT work streams and objectives - talk title TBA

Eva Andres-Mateos, PhD

Associated VP Preclinical Development Gene Therapy @ Eli Lilly

Translational sciences for GT/clinical data - talk title TBA

Shashis Ramaiah, PhD

President, Founder, and CEO @ SPECCRO, Inc.

Derisking Gene Therapy (AAV): Translational Strategies and Emerging Tools to Navigate Safety Risks

Brian Furmanski, PhD

Chief Regulatory Officer @ Kriya Therapeutics

The Path to First-in-Human: Regulatory and Strategic Considerations for CGT IND Submissions 

Jim MacKrell, PhD

Lilly Ventures - VP & Global Head of Science Team @ Eli Lill

Amy Rosenberg, PhD

Senior Director Regulatory Affairs @ Regeneron

Success of CAR-T Cells in Treatment of Autoimmunity: Broader Application to Disease Treatment & Prevention Including Immunogenicity of Therapeutic Proteins

Matt Silva, PhD

CEO @ EMIT Imaging

Cryo-Fluorescence Tomography: Transformative 3D Imaging for Gene & Cell Therapy 

Aman Singh, PhD

Group Director - Clinical Pharmacology & Pharmacometrics @ Johnson & Johnson

SLE CAR-T modeling - talk title TAB

Stephen Wang, PhD

Associate Director @ Novartis Gene Therapies

preclinical and clinical regulatory aspects of the autologous hematopoietic stem cell (HSC) delivery of DFT383 for nephropathic cystinosis - Title TBA

Joleen White, PhD

Senior Consultant @ BioData Solutions

Evaluating Immunogenicity in Cell and Gene Therapies

Mandy Xie, PhD

Executive Director, Head of Analytical Development & Attribute Science @ Bristol Myers Squibb

insight into operational efficiencies around CART manufacturing - Title TBA